Cargando…

Empagliflozin mitigates type 2 diabetes-associated peripheral neuropathy: a glucose-independent effect through AMPK signaling

Diabetic peripheral neuropathy (DPN) represents a severe microvascular condition that dramatically affects diabetic patients despite adequate glycemic control, resulting in high morbidity. Thus, recently, anti-diabetic drugs that possess glucose-independent mechanisms attracted attention. This work...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdelkader, Noha F., Elbaset, Marawan A., Moustafa, Passant E., Ibrahim, Sherehan M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pharmaceutical Society of Korea 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325846/ https://www.ncbi.nlm.nih.gov/pubmed/35767208 http://dx.doi.org/10.1007/s12272-022-01391-5

Ejemplares similares

Erythropoietin mitigated thioacetamide-induced renal injury via JAK2/STAT5 and AMPK pathway
por: Elbaset, Marawan A., et al.
Publicado: (2023)

Erythropoietin Suppresses the Hepatic Fibrosis Caused by Thioacetamide: Role of the PI3K/Akt and TLR4 Signaling Pathways
por: Elbaset, Marawan A., et al.
Publicado: (2023)

Effect of Empagliflozin on Thioacetamide-Induced Liver Injury in Rats: Role of AMPK/SIRT-1/HIF-1α Pathway in Halting Liver Fibrosis
por: ElBaset, Marwan A., et al.
Publicado: (2022)

Effectiveness of Empagliflozin With Vitamin D Supplementation in Peripheral Neuropathy in Type 2 Diabetic Patients
por: Mehta, Sanjana, et al.
Publicado: (2021)

Rosiglitazone Mitigates Dexamethasone-Induced Depression in Mice via Modulating Brain Glucose Metabolism and AMPK/mTOR Signaling Pathway
por: Alhaddad, Aisha, et al.
Publicado: (2023)

Dapagliflozin as an autophagic enhancer via LKB1/AMPK/SIRT1 pathway in ovariectomized/d-galactose Alzheimer’s rat model
por: Ibrahim, Weam W., et al.
Publicado: (2022)

Glucose Enhances Leptin Signaling through Modulation of AMPK Activity
por: Su, Haoran, et al.
Publicado: (2012)

Economic Spectrofluorometric Bioanalysis of Empagliflozin in Rats' Plasma
por: Ayoub, Bassam, et al.
Publicado: (2021)

Empagliflozin Inhibits Hepatic Gluconeogenesis and Increases Glycogen Synthesis by AMPK/CREB/GSK3β Signalling Pathway
por: Yu, Xiaochen, et al.
Publicado: (2022)

Vagus Nerve Stimulation Transiently Mitigates Chemotherapy-Induced Peripheral Neuropathy in Rats
por: Zhang, Ran, et al.
Publicado: (2020)

Glucose Inhibits Yeast AMPK (Snf1) by Three Independent Mechanisms
por: Simpson-Lavy, Kobi, et al.
Publicado: (2023)

Sodium–Glucose CoTransporter-2 Inhibitor Empagliflozin Ameliorates Sunitinib-Induced Cardiac Dysfunction via Regulation of AMPK–mTOR Signaling Pathway–Mediated Autophagy
por: Ren, Changzhen, et al.
Publicado: (2021)

Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission
por: Zhou, Hao, et al.
Publicado: (2017)

Empagliflozin Alleviates Hepatic Steatosis by Activating the AMPK-TET2-Autophagy Pathway in vivo and in vitro
por: Li, Ting, et al.
Publicado: (2021)

Peripheral neuropathy is associated with insulin resistance independent of metabolic syndrome
por: Han, Ling, et al.
Publicado: (2015)

Compound C Prevents the Unfolded Protein Response during Glucose Deprivation through a Mechanism Independent of AMPK and BMP Signaling
por: Saito, Sakae, et al.
Publicado: (2012)

Therapeutic Benefit of Extended Thymosin β4 Treatment Is Independent of Blood Glucose Level in Mice with Diabetic Peripheral Neuropathy
por: Wang, Lei, et al.
Publicado: (2015)

TNF-Alpha in Peripheral Neuropathy Patients with Impaired Glucose Regulation
por: Li, Xia, et al.
Publicado: (2017)

Empagliflozin Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats by Modulating Sesn2/AMPK/Nrf2 Signaling and Targeting Ferroptosis and Autophagy
por: El-Horany, Hemat El-Sayed, et al.
Publicado: (2023)

Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPKα1/ULK1/FUNDC1/mitophagy pathway
por: Cai, Chen, et al.
Publicado: (2022)

Empagliflozin improves renal ischemia–reperfusion injury by reducing inflammation and enhancing mitochondrial fusion through AMPK–OPA1 pathway promotion
por: Yang, Wenbo, et al.
Publicado: (2023)

Empagliflozin mitigates endothelial inflammation and attenuates endoplasmic reticulum stress signaling caused by sustained glycocalyx disruption
por: Campeau, Marc-Antoine, et al.
Publicado: (2022)

The Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor Empagliflozin Reverses Hyperglycemia-Induced Monocyte and Endothelial Dysfunction Primarily through Glucose Transport-Independent but Redox-Dependent Mechanisms
por: Semo, Dilvin, et al.
Publicado: (2023)

Nmnat mitigates sensory dysfunction in a Drosophila model of paclitaxel-induced peripheral neuropathy
por: Brazill, Jennifer M., et al.
Publicado: (2018)

Inhibition of mitochondrial complex I improves glucose metabolism independently of AMPK activation
por: Hou, Wo‐Lin, et al.
Publicado: (2017)

AMPK Phosphorylation Is Controlled by Glucose Transport Rate in a PKA-Independent Manner
por: Milanesi, Riccardo, et al.
Publicado: (2021)

Antioxidant and Anti-Inflammatory Potential of Thymoquinone and Lycopene Mitigate the Chlorpyrifos-Induced Toxic Neuropathy
por: Aboubakr, Mohamed, et al.
Publicado: (2021)

Glucose activates the primordial follicle through the AMPK/mTOR signaling pathway
por: Xu, Shengyu, et al.
Publicado: (2020)

Testosterone activates glucose metabolism through AMPK and androgen signaling in cardiomyocyte hypertrophy
por: Troncoso, Mayarling Francisca, et al.
Publicado: (2021)

Empagliflozin Attenuates Hyperuricemia by Upregulation of ABCG2 via AMPK/AKT/CREB Signaling Pathway in Type 2 Diabetic Mice
por: Lu, Yun-hong, et al.
Publicado: (2020)

The Ameliorative Effect of Empagliflozin in Vigabatrin-Induced Cerebellar/Neurobehavioral Deficits: Targeting mTOR/AMPK/SIRT-1 Signaling Pathways
por: Amer, Rabab M., et al.
Publicado: (2022)

Promoting AMPK/SR-A1-mediated clearance of HMGB1 attenuates chemotherapy-induced peripheral neuropathy
por: Yang, Xing, et al.
Publicado: (2023)

Effect of Empagliflozin, a Selective Sodium-Glucose Cotransporter 2 Inhibitor, on Kidney and Peripheral Nerves in Streptozotocin-Induced Diabetic Rats
por: Lee, Kyung Ae, et al.
Publicado: (2018)

Direct small molecule ADaM-site AMPK activators reveal an AMPKγ3-independent mechanism for blood glucose lowering
por: Jørgensen, Nicolas O., et al.
Publicado: (2021)

Empagliflozin Attenuates Vascular Calcification in Mice with Chronic Kidney Disease by Regulating the NFR2/HO-1 Anti-Inflammatory Pathway through AMPK Activation
por: Lu, Chia-Wen, et al.
Publicado: (2023)

Neuroprotective effect of liraglutide in an experimental mouse model of multiple sclerosis: role of AMPK/SIRT1 signaling and NLRP3 inflammasome
por: Ammar, Reham A., et al.
Publicado: (2022)

Metformin suppresses adipogenesis through both AMP-activated protein kinase (AMPK)-dependent and AMPK-independent mechanisms
por: Chen, Suet Ching, et al.
Publicado: (2017)

Association of Organochlorine Pesticides with Peripheral Neuropathy in Patients with Diabetes or Impaired Fasting Glucose
por: Lee, Duk-Hee, et al.
Publicado: (2008)

Metformin Protects From Rotenone–Induced Nigrostriatal Neuronal Death in Adult Mice by Activating AMPK-FOXO3 Signaling and Mitigation of Angiogenesis
por: El-Ghaiesh, Sabah H., et al.
Publicado: (2020)

Empagliflozin Regulates the AdipoR1/p-AMPK/p-ACC Pathway to Alleviate Lipid Deposition in Diabetic Nephropathy
por: Zhang, Zhiqin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7eanqm9qmbvab7p9g24k0866k1